Cell cycle inhibitor, p19INK4d, promotes cell survival and decreases chromosomal aberrations after genotoxic insult due to enhanced DNA repair

DNA Repair

Volumn 6, Issue 5, 2007, Pages 626-638

  Scassa, María E ^a   Marazita, Mariela C ^a,c   Ceruti, Julieta M ^a   Carcagno, Abel L ^a   Sirkin, Pablo F ^a   González Cid, Marcela ^b   Pignataro, Omar P ^a,c   Cánepa, Eduardo T ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Apoptosis; Cell survival; Chromosomal aberrations; DNA repair; Genotoxic; p19INK4d

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2D; PHOSPHORUS 32; RNA;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CELL VIABILITY; CHROMOSOME ABERRATION; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA SYNTHESIS; FLOW CYTOMETRY; GENOTOXICITY; GROWTH INHIBITION; ISOTOPE LABELING; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; TUMOR CELL CULTURE; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL SURVIVAL; CHROMOSOME ABERRATIONS; COLONY-FORMING UNITS ASSAY; CYCLIN-DEPENDENT KINASE INHIBITOR P19; DNA DAMAGE; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; IMMUNOPRECIPITATION; MICE; PYRIMIDINE DIMERS; RADIATION TOLERANCE; RNA, MESSENGER; THYMIDINE; ULTRAVIOLET RAYS;

EID: 34047171404     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.12.003     Document Type: Article

References (60)

1. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
2. Lukas J., Lukas C., and Bartek J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst) 3 (2004) 997-1007
3. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73 (2004) 39-85
4. Burtelow M.A., Roos-Mattjus P.M., Rauen M., Babendure J.R., and Karnitz L.M. Reconstitution and molecular analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA damage responsive checkpoint complex. J. Biol. Chem. 276 (2001) 25903-25909
5. Griffith J.D., Lindsey-Boltz L.A., and Sancar A. Structures of the human Rad17-replication factor C and checkpoint Rad 9-1-1 complexes visualized by glycerol spray/low voltage microscopy. J. Biol. Chem. 277 (2002) 15233-15236
6. Difilippantonio S., Celeste A., Fernandez-Capetillo O., Chen H.T., Reina San Martin B., Van Laethem F., Yang Y.P., Petukhova G.V., Eckhaus M., Feigenbaum L., Manova K., Kruhlak M., Camerini-Otero R.D., Sharan S., Nussenzweig M., and Nussenzweig A. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol. 7 (2005) 675-685
7. Petrini J.H., and Stracker T.H. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends. Cell Biol. 13 (2003) 458-462
8. Yoo H.Y., Kumagai A., Shevchenko A., and Dunphy W.G. Adaptation of a DNA replication checkpoint response depends upon inactivation of Claspin by the Polo-like kinase. Cell 117 (2004) 575-588
9. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., and Jackson S.P. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8 (2006) 37-45
10. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3 (2003) 155-168
11. Heffernan T.P., Simpson D.A., Frank A.R., Heinloth A.N., Paules R.S., Cordeiro-Stone M., and Kaufmann W.K. An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage. Mol. Cell Biol. 22 (2002) 8552-8561
12. Bartek J., and Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3 (2003) 421-429
13. Donzelli M., and Draetta G.F. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 4 (2003) 671-677
14. Zhou B.B., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439
15. Norbury C.J., and Zhivotovsky B. DNA damage-induced apoptosis. Oncogene 23 (2004) 2797-2808
16. Zhivotovsky B., and Kroemer G. Apoptosis and genomic instability. Nat. Rev. Mol. Cell Biol. 5 (2004) 752-762
17. Rouse J., and Jackson S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science 297 (2002) 547-551
18. D'Andrea A.D., and Grompe M. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3 (2003) 23-34
19. Rooney S., Alt F.W., Lombard D., Whitlow S., Eckersdorff M., Fleming J., Fugmann S., Ferguson D.O., Schatz D.G., and Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med. 197 (2003) 553-565
20. Roth D.B. Amplifying mechanisms of lymphomagenesis. Mol. Cell 10 (2002) 1-2
21. Sekiguchi J., Ferguson D.O., Chen H.T., Yang E.M., Earle J., Frank K., Whitlow S., Gu Y., Xu Y., Nussenzweig A., and Alt F.W. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3243-3248
22. Allard S., Masson J.Y., and Cote J. Chromatin remodeling and the maintenance of genome integrity. Biochim. Biophys. Acta 1677 (2004) 158-164
23. Rubbi C.P., and Milner J. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. Embo. J. 22 (2003) 975-986
24. Alano C.C., Ying W., and Swanson R.A. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J. Biol. Chem. 279 (2004) 18895-18902
25. Hickman M.J., and Samson L.D. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell 14 (2004) 105-116
26. M.A. Al-Mohanna, P.S. Manogaran, Z. Al-Mukhalafi, K.A.Al-Hussein, A. Aboussekhra, The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin, Oncogene 23 (2004) 201-212.
27. Ceruti J.M., Scassa M.E., Flo J.M., Varone C.L., and Canepa E.T. Induction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cells. Oncogene 24 (2005) 4065-4080
28. Roussel M.F. The INK4 family of cell cycle inhibitors in cancer. Oncogene 18 (1999) 5311-5317
29. Pei X.H., and Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24 (2005) 2787-2795
30. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., Beach D., and Serrano M. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) 642
31. Cunningham J.J., and Roussel M.F. Cyclin-dependent kinase inhibitors in the development of the central nervous system. Cell Growth Differ. 12 (2001) 387-396
32. Zindy F., Cunningham J.J., Sherr C.J., Jogal S., Smeyne R.J., and Roussel M.F. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13462-13467
33. Sharpless N.E., Ramsey M.R., Balasubramanian P., Castrillon D.H., and DePinho R.A. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23 (2004) 379-385
34. Bai F., Pei X.H., Godfrey V.L., and Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol. Cell Biol. 23 (2003) 1269-1277
35. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology 108 (1981) 88-95
36. Scassa M.E., Guberman A.S., Ceruti J.M., and Canepa E.T. Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression. J. Biol. Chem. 279 (2004) 28082-28092
37. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
38. Newton Bishop J.A., Harland M., Bennett D.C., Bataille V., Goldstein A.M., Tucker M.A., Ponder B.A., Cuzick J., Selby P., and Bishop D.T. Mutation testing in melanoma families: INK4A, CDK4 and INK4D. Br. J. Cancer 80 (1999) 295-300
39. Varone C.L., Giono L.E., Ochoa A., Zakin M.M., and Canepa E.T. Transcriptional regulation of 5-aminolevulinate synthase by phenobarbital and cAMP-dependent protein kinase. Arch. Biochem. Biophys. 372 (1999) 261-270
40. Giono L.E., Varone C.L., and Canepa E.T. 5-Aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB). Biochem. J. 353 (2001) 307-316
41. Koberle B., Roginskaya V., and Wood R.D. XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells. DNA Repair (Amst) 5 (2006) 641-648
42. Guan K.L., Jenkins C.W., Li Y., O'Keefe C.L., Noh S., Wu X., Zariwala M., Matera A.G., and Xiong Y. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell 7 (1996) 57-70
43. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1 (2001) 22-33
44. Chipchase M.D., and Melton D.W. The formation of UV-induced chromosome aberrations involves ERCC1 and XPF but not other nucleotide excision repair genes. DNA Repair (Amst) 1 (2002) 335-340
45. Sotillo R., Dubus P., Martin J., de la Cueva E., Ortega S., Malumbres M., and Barbacid M. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. Embo. J. 20 (2001) 6637-6647
46. Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
47. Hahn W.C., and Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2 (2002) 331-341
48. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes. Dev. 13 (1999) 1501-1512
49. Lin W.C., Lin F.T., and Nevins J.R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15 (2001) 1833-1844
50. Stevens C., and La Thangue N.B. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 3 (2004) 1071-1079
51. Gong F., Kwon Y., and Smerdon M.J. Nucleotide excision repair in chromatin and the right of entry. DNA Repair (Amst) 4 (2005) 884-896
52. Mellon I. Transcription-coupled repair: a complex affair. Mutat. Res. 577 (2005) 155-161
53. Svejstrup J.Q. Transcription repair coupling factor: a very pushy enzyme. Mol. Cell 9 (2002) 1151-1152
54. Sarker A.H., Tsutakawa S.E., Kostek S., Ng C., Shin D.S., Peris M., Campeau E., Tainer J.A., Nogales E., and Cooper P.K. Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome. Mol. Cell 20 (2005) 187-198
55. Tavera-Mendoza L.E., Wang T.T., and White J.H. p19INK4D and cell death. Cell Cycle 5 (2006) 596-598
56. Tavera-Mendoza L., Wang T.T., Lallemant B., Zhang R., Nagai Y., Bourdeau V., Ramirez-Calderon M., Desbarats J., Mader S., and White J.H. Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 7 (2006) 180-185
57. Laurent E., Mitchell D.L., Estrov Z., Lowery M., Tucker S.L., Talpaz M., and Kurzrock R. Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair. Clin. Cancer Res. 9 (2003) 3722-3730
58. Bartkova J., Thullberg M., Rajpert-De Meyts E., Skakkebaek N.E., and Bartek J. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 19 (2000) 4146-4150
59. Chatterjee R., Haines G.A., Perera D.M., Goldstone A., and Morris I.D. Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum. Reprod. 15 (2000) 762-766
60. Zindy F., van Deursen J., Grosveld G., Sherr C.J., and Roussel M.F. INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell Biol. 20 (2000) 372-378